Carestream nets European contracts

TriMed Staff | | Health Imaging | Practice Management
Carestream Health has signed contracts for its Kodak Carestream RIS/PACS platforms and its Carestream Business Diagnostics with 12 European healthcare facilities.

The company’s Business Diagnostics is a consulting service that employs lean-methodology processes to improve the efficiency and performance of radiology processes.

The healthcare providers that have placed orders for Carestream’s information management systems and services include: Het Groene Hart Ziedenhuis in Gouda, The Netherlands; Hospital Cardarelli in Naples, Italy; Marienhaus Klinikum Neuwied in Neuwied, Germany; Parkside Hospital in London; and Syöpäjärjestöjen Poliklinikka  in Helsinki, Finland.

TriMed Staff

Related Content

MRI accident has prompted the company that installed the scanner to issue a safety warning
Newly launched report feature provides patients with a visual aid to their imaging
Center for Devices and Radiological Health hit with federal job cuts
Overview of the regulatory landscape of AI in radiology
Concerns about private equity's growing influence in radiology
'Ad hoc' shifts and radiology 'maestros': How one department addressed its workflow hiccups

Around the web

Cardiovascular Business
GE HealthCare launches new cardiac CT scanner with advanced AI capabilities

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Cardiovascular Business
Bracco updates HeartSee coronary flow capacity software with new diagnostic features

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

Cardiovascular Business
Key trends in diagnostic heart testing: CT on the rise as some traditional techniques fall out of favor

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.